Sibel Health Expands Capabilities with New FDA Clearances for ANNE® Wearable Sensors

Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. I...

August 23, 2024 | Friday | News
Monkeypox Resurgence: What the Data Reveals About Its Spread and Global Impact

  Mpox is an infectious disease spread through close contact with contagious individuals or infected animals. Most people recover fully, but in some ...

August 21, 2024 | Wednesday | Reports
Roche Strengthens Global Response to Mpox Outbreak with Advanced PCR Testing Solutions

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) te...

August 21, 2024 | Wednesday | News
GE HealthCare Partners with UC San Diego to Enhance MRI Techniques for Women's Pelvic Health

Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic di...

August 20, 2024 | Tuesday | News
Emergent BioSolutions Collaborates with WHO and U.S. Government to Combat Mpox Outbreak in Central Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...

August 20, 2024 | Tuesday | News
Bavarian Nordic Ramps Up Mpox Vaccine Production Amid Africa CDC's Public Health Emergency Declaration

Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers f...

August 19, 2024 | Monday | News
Pfizer and BioNTech's Ambitious Combo Vaccine Shows Promise but Faces Hurdles in Phase 3 Trial

In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicit...

August 19, 2024 | Monday | News
Fapon Biotech Strengthens Global Response to Monkeypox with Innovative Antigen Diagnostics

  Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...

August 19, 2024 | Monday | News
Lykos Therapeutics Restructures to Focus on Resubmission of NDA for PTSD Treatment Midomafetamine

Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, today announced a reorganization to best support the company as...

August 16, 2024 | Friday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Mangoceuticals Secures 20-Year Patent in India for Innovative Preventive Health Technology

Mangoceuticals, Inc. \ a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of ...

August 14, 2024 | Wednesday | News
HERA and Bavarian Nordic to Deliver 215,000 Doses of Mpox Vaccine to Africa Amidst Rapid Outbreak

HERA will procure 175,420 doses for immediate response to the concerning mpox outbreak in Africa, and furthermore, Bavarian Nordic will donate 40,000 d...

August 14, 2024 | Wednesday | News
Angiex Initiates Phase 1 Clinical Trial for AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Tumors

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...

August 09, 2024 | Friday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close